Clinical Trial: A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Alzheimers Disease
Study Type: INTERVENTIONAL
Official Title: A Randomised Double-blind Placebo-controlled Clinical Study Investigating the Effects of Semaglutide s.c. Once-weekly Versus Placebo on Central and Peripheral Inflammation in Participants With Alzheim
Brief Summary:
The study is being conducted to understand how the medicine, semaglutide, affects the immune system and other biological processes in people with Alzheimer's disease.Semaglutide is a medicine that doctors can prescribe in some countries for the treatment of type 2 diabetes and excess body weight.This study will help us understand whether semaglutide can also be used for the treatment of Alzheimer's disease.The study will last for about 77 weeks.In the first 12 weeks of treatment, participants will either…
Read more